Comparative review of the blood pressure-lowering and cardiovascular benefits of telmisartan and perindopril

Hypertension is a major cardiovascular (CV) risk factor, and blood pressure (BP)-lowering treatment substantially reduces the risk. This review compares the available clinical evidence from the BP-lowering and CV-outcome studies of telmisartan and perindopril, which are among the most intensively st...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ji-Guang, Pimenta, Eduardo, Chwallek, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983078/
https://www.ncbi.nlm.nih.gov/pubmed/24741317
http://dx.doi.org/10.2147/VHRM.S59429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983078/
https://www.ncbi.nlm.nih.gov/pubmed/24741317
http://dx.doi.org/10.2147/VHRM.S59429

Ejemplares similares